Your browser doesn't support javascript.
loading
Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.
Guo, Qie; Sui, Zhong-Guo; Xu, Wen; Quan, Xiang-Hua; Sun, Jia-Lin; Li, Xiao; Ji, Hong-Yan; Jing, Fan-Bo.
Afiliación
  • Guo Q; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Sui ZG; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Xu W; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Quan XH; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Sun JL; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Li X; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Ji HY; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
  • Jing FB; Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China.
Oncotarget ; 8(42): 72652-72665, 2017 Sep 22.
Article en En | MEDLINE | ID: mdl-29069816

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos